Vascular Biology – Hemodynamics – Hypertension
Kidney International (2005) 67, 1899–1906; doi:10.1111/j.1523-1755.2005.00288.x
Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression
MARIO BONOMINI, ASSUNTA PANDOLFI, NATALIA DI PIETRO, VITTORIO SIROLLI, ANNALISA GIARDINELLI, AGOSTINO CONSOLI, LUIGI AMOROSO, FEDERICO GIZZI, MARIA ANNA DE LUTIIS and MARIO FELACO
Department of Medicine, Institute of Nephrology; Aging Research Center, Ce.S.I., "G. d'Annunzio" University Foundation; Department of Biomorphology; Department of Medicine and Aging Science, University "G. d'Annunzio," Chieti-Pescara, Italy
Correspondence: Prof Mario Bonomini, M.D., Clinica Nefrologica-Emodialisi, Ospedale Clinicizzato "SS. Annunziata," Via dei Vestini, 66013 Chieti, Italy. E-mail: m.bonomini@nephro.unich.it
Received 7 August 2004; Revised 28 October 2004; Accepted 23 November 2004.
Abstract
Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression.
Background
High prevalence of atherosclerotic cardiovascular events accounts for much of the mortality among patients suffering from end-stage renal disease (ESRD). Endothelial dysfunction as a pathogenic mechanism might contribute to increasing the cardiovascular risk of ESRD. Reduced endothelium-dependent vasodilation has consistently been observed in chronic renal failure patients. Since nitric oxide (NO) is the principal endothelium-derived vasodilator, a reduction in the NO bioavailability may be envisaged in ESRD patients.
Methods
To clarify whether exposure to erythrocytes from ESRD patients might modulate NO release by the endothelium, we evaluated endothelial NO synthase (eNOS) protein levels (Western blot), eNOS mRNA quantity (real-time PCR), and NOS activity (conversion of L-[3H] arginine in L-[3H] citruline) in endothelial cultures stimulated by erythrocytes from healthy subjects and ESRD patients.
Results
A time-dependent decrease in eNOS protein levels was evident in cultures treated with erythrocytes from ESRD patients. This observation was consistent with the decreased eNOS mRNA quantities induced by erythrocytes from such patients. Moreover, compared to controls, NOS activity exhibited a significant reduction after incubation with erythrocytes from ESRD patients. The observed eNOS reduction induced by erytrocytes from ESRD patients was totally abolished by annexin V, able to mask red blood cell (RBC) surface-exposed phosphatidylserine.
Conclusion
These findings suggest that adhesion of erythrocytes from ESRD patients to vascular endothelium may cause a decrease in the levels of eNOS mRNA and protein, and inhibition of NOS activity. This might contribute to endothelial dysfunction, and may play a role in the pathogenesis of cardiovascular disease in ESRD patients.
Keywords:
endothelial nitric oxide synthase, erythrocyte, uremia
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Arginine, arginine analogs and nitric oxide production in chronic kidney disease
Nature Clinical Practice Nephrology Review (01 Apr 2006)
RESEARCH
Kidney International Original Article
Oral L -arginine does not improve endothelial dysfunction in children with chronic renal failure
Kidney International Original Article
Nitric oxide in uremia: Effects of several potentially toxic guanidino compounds
Kidney International Original Article
Effect of asymmetric dimethylarginine on osteoblastic differentiation
Kidney International Original Article


